Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 53
Filter
Add more filters










Publication year range
1.
Ann Neurol ; 79(3): 379-86, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26642834

ABSTRACT

OBJECTIVE: Succinate dehydrogenase-deficient leukoencephalopathy is a complex II-related mitochondrial disorder for which the clinical phenotype, neuroimaging pattern, and genetic findings have not been comprehensively reviewed. METHODS: Nineteen individuals with succinate dehydrogenase deficiency-related leukoencephalopathy were reviewed for neuroradiological, clinical, and genetic findings as part of institutional review board-approved studies at Children's National Health System (Washington, DC) and VU University Medical Center (Amsterdam, the Netherlands). RESULTS: All individuals had signal abnormalities in the central corticospinal tracts and spinal cord where imaging was available. Other typical findings were involvement of the cerebral hemispheric white matter with sparing of the U fibers, the corpus callosum with sparing of the outer blades, the basis pontis, middle cerebellar peduncles, and cerebellar white matter, and elevated succinate on magnetic resonance spectroscopy (MRS). The thalamus was involved in most studies, with a predilection for the anterior nucleus, pulvinar, and geniculate bodies. Clinically, infantile onset neurological regression with partial recovery and subsequent stabilization was typical. All individuals had mutations in SDHA, SDHB, or SDHAF1, or proven biochemical defect. INTERPRETATION: Succinate dehydrogenase deficiency is a rare leukoencephalopathy, for which improved recognition by magnetic resonance imaging (MRI) in combination with advanced sequencing technologies allows noninvasive diagnostic confirmation. The MRI pattern is characterized by cerebral hemispheric white matter abnormalities with sparing of the U fibers, corpus callosum involvement with sparing of the outer blades, and involvement of corticospinal tracts, thalami, and spinal cord. In individuals with infantile regression and this pattern of MRI abnormalities, the differential diagnosis should include succinate dehydrogenase deficiency, in particular if MRS shows elevated succinate.


Subject(s)
Leukoencephalopathies/enzymology , Leukoencephalopathies/pathology , Magnetic Resonance Imaging/methods , Spinal Cord/pathology , Succinate Dehydrogenase/deficiency , Thalamus/pathology , Female , Humans , Infant , Infant, Newborn , Male , Pyramidal Tracts/enzymology , Pyramidal Tracts/pathology , Spinal Cord/enzymology , Thalamus/enzymology
2.
Cell Death Dis ; 6: e1638, 2015 Feb 12.
Article in English | MEDLINE | ID: mdl-25675298

ABSTRACT

Prolyl 4-hydroxylases (PHDs; PHD1, PHD2, and PHD3) are a component of cellular oxygen sensors that regulate the adaptive response depending on the oxygen concentration stabilized by hypoxia/stress-regulated genes transcription. In normoxic condition, PHD2 is required to stabilize hypoxia inducible factors. Silencing of PHD2 leads to the activation of intracellular signaling including RhoA and Rho-associated protein kinase (ROCK), which are key regulators of neurite growth. In this study, we determined that genetic or pharmacological inhibition of PHD2 in cultured cortical neurons prevents neurite elongation through a ROCK-dependent mechanism. We then explored the role of PHDs in axonal reorganization following a traumatic brain injury in adult mice. Unilateral destruction of motor cortex resulted in behavioral deficits due to disruption of the corticospinal tract (CST), a part of the descending motor pathway. In the spinal cord, sprouting of fibers from the intact side of the CST into the denervated side is thought to contribute to the recovery process following an injury. Intracortical infusion of PHD inhibitors into the intact side of the motor cortex abrogated spontaneous formation of CST collaterals and functional recovery after damage to the sensorimotor cortex. These findings suggest PHDs have an important role in the formation of compensatory axonal networks following an injury and may represent a new molecular target for the central nervous system disorders.


Subject(s)
Brain Injuries/enzymology , Brain Injuries/metabolism , Prolyl Hydroxylases/metabolism , Animals , Axons , Cells, Cultured , Hypoxia-Inducible Factor-Proline Dioxygenases/antagonists & inhibitors , Hypoxia-Inducible Factor-Proline Dioxygenases/metabolism , Mice , Mice, Inbred C57BL , Neurites/enzymology , Neurites/metabolism , Neurons/cytology , Neurons/drug effects , Neurons/metabolism , Pyramidal Tracts/enzymology , Pyramidal Tracts/metabolism , Recovery of Function/physiology , rho-Associated Kinases/metabolism
3.
Cereb Cortex ; 24(11): 3069-79, 2014 Nov.
Article in English | MEDLINE | ID: mdl-23810979

ABSTRACT

Our previous study shows that conventional protein kinases C (cPKCs) are key signaling mediators that are activated by extracellular inhibitory molecules. Inhibition of cPKC by intrathecal infusion of a cPKC inhibitor, GÖ6976, into the site of dorsal hemisection (DH) induces regeneration of lesioned dorsal column sensory, but not corticospinal tract (CST), axons. Here, we investigated whether a direct cortical delivery of GÖ6976 into the soma of corticospinal neurons promotes regeneration of CST and the recovery of forelimb function in rats with cervical spinal cord injuries. We report that cortical delivery of GÖ6976 reduced injury-induced activation of conventional PKCα and PKCß1 in CST neurons, promoted regeneration of CST axons through and beyond a cervical DH at C4, formed new synapses on target neurons caudal to the injury, and enhanced forelimb functional recovery in adult rats. When combined with lenti-Chondroitinase ABC treatment, cortical administration of GÖ6976 promoted even greater CST axonal regeneration and recovery of forelimb function. Thus, this study has demonstrated a novel strategy that can promote anatomical regeneration of damaged CST axons and partial recovery of forelimb function. Importantly, such an effect is critically dependent on the efficient blockage of injury-induced PKC activation in the soma of layer V CST neurons.


Subject(s)
Cerebral Cortex/enzymology , Forelimb/physiology , Functional Laterality/physiology , Nerve Regeneration/physiology , Protein Kinase C/metabolism , Pyramidal Tracts/enzymology , Recovery of Function/physiology , Spinal Cord Injuries/physiopathology , Animals , Biotin/analogs & derivatives , Carbazoles/therapeutic use , Cells, Cultured , Cerebral Cortex/drug effects , Chondroitin ABC Lyase/therapeutic use , Dextrans , Disease Models, Animal , Embryo, Mammalian , Enzyme Inhibitors/therapeutic use , Female , Glial Fibrillary Acidic Protein/metabolism , Male , Nerve Regeneration/drug effects , Neurons/cytology , Neurons/drug effects , Neurons/physiology , Pregnancy , Psychomotor Performance/drug effects , Pyramidal Tracts/drug effects , Rats , Rats, Sprague-Dawley , Recovery of Function/drug effects , Spinal Cord Injuries/drug therapy
4.
Cell Death Dis ; 4: e567, 2013 Apr 04.
Article in English | MEDLINE | ID: mdl-23559001

ABSTRACT

Reorganization of spared neural network connections is one of the most important processes for restoring impaired function after brain injury. However, plasticity is quite limited in the adult brain due to the presence of inhibitory molecules and a lack of intrinsic neuronal signals for axonal growth. Src homology 2-containing phosphatase (SHP)-1 has been shown to have a role in axon growth inhibition. Here, we tested the hypothesis that SHP-1 negatively affects axonal reorganization. We observed that unilateral motor cortex injury led to increased expression and activity of SHP-1 in the contralesional cortex. In this model, corticospinal axons originating from the contralesional cortex sprouted into the denervated side of the cervical spinal cord after injury. We observed that the number of sprouting fibers was increased in SHP-1-deficient heterozygous viable motheaten (+/me(v)) mice, which show reduced SHP-1 activity, and in wild-type mice treated with an SHP inhibitor. Motor function recovery of impaired forelimb was enhanced in +/me(v) mice. Collectively, our results indicate that downregulation of SHP-1 activity promotes corticospinal tract sprouting and functional recovery after brain injury.


Subject(s)
Brain Injuries/drug therapy , Enzyme Inhibitors/pharmacology , Motor Cortex/drug effects , Protein Tyrosine Phosphatase, Non-Receptor Type 6/antagonists & inhibitors , Pyramidal Tracts/drug effects , Quinolines/pharmacology , Recovery of Function , Animals , Axons/drug effects , Axons/physiology , Brain Injuries/metabolism , Down-Regulation , Forelimb/drug effects , Forelimb/physiology , Heterozygote , Male , Mice , Motor Cortex/injuries , Motor Cortex/physiology , Nerve Fibers/drug effects , Nerve Fibers/physiology , Nerve Regeneration/drug effects , Nerve Regeneration/physiology , Protein Tyrosine Phosphatase, Non-Receptor Type 6/deficiency , Pyramidal Tracts/enzymology , Pyramidal Tracts/injuries
5.
J Neuroimmunol ; 256(1-2): 43-8, 2013 Mar 15.
Article in English | MEDLINE | ID: mdl-23385082

ABSTRACT

In the spinal cord, PKCγ is an important kinase found in a specific subset of excitatory interneurons in the superficial dorsal horn and in axons of the corticospinal tract (CST). The major interest in spinal PKCγ has been its influences on regulating pain sensitivity but its presence in the CST also indicates that it has a significant role in locomotor function. A hallmark feature of the animal model commonly used to study Multiple Sclerosis, experimental autoimmune encephalolomyelitis (EAE) are motor impairments associated with the disease. More recently, it has also become recognized that EAE is associated with significant changes in pain sensitivity. Given its role in generating pain hypersensitivity and its presence in a major tract controlling motor activity, we set out to characterize whether EAE was associated with changes PKCγ levels in the spinal cord. We show here that EAE triggers a significant reduction in the levels of PKCγ, primarily in the CST. We did not observe any significant changes in PKCγ levels in the superficial dorsal horn but in general the levels tended to be below control levels in this region. In a final experiment we assessed the levels of PKCγ in the spinal cord of EAE mice that had recovered gross locomotor function and compared this to the levels found in EAE mice with chronic deficits. Our findings demonstrate that PKCγ levels are dynamic and that in later stages of the disease, its expression is dependent on the degree of motor function in the model. Taken together these results suggest that PKCγ may be a useful marker in the disease to monitor the status of the CST.


Subject(s)
Encephalomyelitis, Autoimmune, Experimental/pathology , Gene Expression Regulation, Enzymologic/physiology , Protein Kinase C/metabolism , Pyramidal Tracts/enzymology , Animals , Biomarkers/metabolism , Disease Models, Animal , Encephalomyelitis, Autoimmune, Experimental/physiopathology , Female , Mice , Mice, Inbred C57BL , Time Factors
6.
J Neurosci Methods ; 201(1): 228-38, 2011 Sep 30.
Article in English | MEDLINE | ID: mdl-21855577

ABSTRACT

Several diseases and injuries of the central nervous system could potentially be treated by delivery of an enzyme, which might most effectively be achieved by gene therapy. In particular, the bacterial enzyme chondroitinase ABC is beneficial in animal models of spinal cord injury. We have adapted the chondroitinase gene so that it can direct secretion of active chondroitinase from mammalian cells, and inserted it into lentiviral vectors. When injected into adult rat brain, these vectors lead to extensive secretion of chondroitinase, both locally and from long-distance axon projections, with activity persisting for more than 4 weeks. In animals which received a simultaneous lesion of the corticospinal tract, the vector reduced axonal die-back and promoted sprouting and short-range regeneration of corticospinal axons. The same beneficial effects on damaged corticospinal axons were observed in animals which received the chondroitinase lentiviral vector directly into the vicinity of a spinal cord lesion.


Subject(s)
Cerebral Cortex/enzymology , Chondroitin ABC Lyase/genetics , Gene Expression Regulation, Enzymologic , Genetic Vectors/genetics , Lentivirus/genetics , Nerve Regeneration/genetics , Spinal Cord Injuries/enzymology , Animals , Cells, Cultured , Chondroitin ABC Lyase/administration & dosage , Chondroitin ABC Lyase/biosynthesis , Genetic Vectors/administration & dosage , Genetic Vectors/biosynthesis , HEK293 Cells , Humans , Male , Mice , Pyramidal Tracts/enzymology , Rats , Sheep , Spinal Cord Injuries/genetics
7.
J Neurosci ; 29(27): 8816-27, 2009 Jul 08.
Article in English | MEDLINE | ID: mdl-19587289

ABSTRACT

Corticospinal tract (CST) connections to spinal interneurons are conserved across species. We identified spinal interneuronal populations targeted by the CST in the cervical enlargement of the cat during development. We focused on the periods before and after laminar refinement of the CST terminations, between weeks 5 and 7. We used immunohistochemistry of choline acetyltransferase (ChAT), calbindin, calretinin, and parvalbumin to mark interneurons. We first compared interneuron marker distribution before and after CST refinement. ChAT interneurons increased, while calbindin interneurons decreased during this period. No significant changes were noted in parvalbumin and calretinin. We next used anterograde labeling to determine whether the CST targets different interneuron populations before and after the refinement period. Before refinement, the CST terminated sparsely where calbindin interneurons were located and spared ChAT interneurons. After refinement, the CST no longer terminated in calbindin-expressing areas but did so where ChAT interneurons were located. Remarkably, early CST terminations were dense where ChAT interneurons later increased in numbers. Finally, we determined whether corticospinal system activity was necessary for the ChAT and calbindin changes. We unilaterally inactivated M1 between weeks 5 and 7 by muscimol infusion. Inactivation resulted in a distribution of calbindin and ChAT in spinal gray matter regions where the CST terminates that resembled the immature more than mature pattern. Our results show that the CST plays a crucial role in restructuring spinal motor circuits during development, possibly through trophic support, and provide strong evidence for the importance of connections with key spinal interneuron populations in development of motor control functions.


Subject(s)
Cervical Vertebrae/growth & development , Cervical Vertebrae/innervation , Interneurons/physiology , Pyramidal Tracts/growth & development , Action Potentials/physiology , Animals , Cats , Cell Differentiation/physiology , Cervical Vertebrae/enzymology , Choline O-Acetyltransferase/biosynthesis , Choline O-Acetyltransferase/genetics , Female , Interneurons/cytology , Interneurons/enzymology , Neurogenesis/physiology , Pyramidal Tracts/enzymology , Spinal Cord/cytology , Spinal Cord/enzymology , Spinal Cord/growth & development
8.
J Neurosci ; 26(1): 126-37, 2006 Jan 04.
Article in English | MEDLINE | ID: mdl-16399679

ABSTRACT

In the adult mammalian brain, brain-derived neurotrophic factor (BDNF) is critically involved in long-term synaptic plasticity. Here, we show that supraspinal BDNF-tyrosine kinase receptor B (TrkB) signaling contributes to pain facilitation. We show that BDNF-containing neurons in the periaqueductal gray (PAG), the central structure for pain modulation, project to and release BDNF in the rostral ventromedial medulla (RVM), a relay between the PAG and spinal cord. BDNF in PAG and TrkB phosphorylation in RVM neurons are upregulated after inflammation. Intra-RVM sequestration of BDNF and knockdown of TrkB by RNA interference attenuate inflammatory pain. Microinjection of BDNF (10-100 fmol) into the RVM facilitates nociception, which is dependent on NMDA receptors (NMDARs). In vitro studies with RVM slices show that BDNF induces tyrosine phosphorylation of the NMDAR NR2A subunit in RVM via a signal transduction cascade involving IP(3), PKC, and Src. The supraspinal BDNF-TrkB signaling represents a previously unknown mechanism underlying the development of persistent pain. Our findings also caution that application of BDNF for recovery from CNS disorders could lead to undesirable central pain.


Subject(s)
Brain-Derived Neurotrophic Factor/physiology , Medulla Oblongata/metabolism , Pain/metabolism , Pyramidal Tracts/physiology , Receptor, trkB/physiology , Signal Transduction/physiology , Animals , Brain-Derived Neurotrophic Factor/biosynthesis , Brain-Derived Neurotrophic Factor/genetics , Male , Medulla Oblongata/enzymology , Pain/enzymology , Pain/genetics , Pain Measurement/methods , Pyramidal Tracts/enzymology , Rats , Rats, Sprague-Dawley
9.
Neurobiol Dis ; 18(1): 126-33, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15649703

ABSTRACT

Protein kinase C (PKC) was suggested to play a role in the pathology of amyotrophic lateral sclerosis (ALS) patients. Activation of PKC delta (deltaPKC) modulates mitochondrially induced apoptosis. The goal of the present study was to define whether deltaPKC activation occurs in Wobbler mouse spinal cord (a model of motor neuron disease). The level of deltaPKC in the soluble fraction was significantly decreased in the spinal cord of Wobbler mice, which was associated with a significant increase in deltaPKC cleavage. Since caspase-3 is known to cleave deltaPKC, we determined caspase-3 activation in the Wobbler mice spinal cord, immunohistochemically. The results demonstrated intense immunoreactivity for activated caspase-3 in corticospinal tract motor neurons of Wobbler mice spinal cord. We hypothesize from these results that caspase-3 activation cleaves deltaPKC, which in turn promotes an aberrant signal transduction pathway in the Wobbler spinal cord.


Subject(s)
Amyotrophic Lateral Sclerosis/enzymology , Caspases/metabolism , Motor Neuron Disease/enzymology , Motor Neurons/enzymology , Protein Kinase C/metabolism , Spinal Cord/enzymology , Amyotrophic Lateral Sclerosis/genetics , Amyotrophic Lateral Sclerosis/pathology , Animals , Caspase 3 , Disease Models, Animal , Down-Regulation/physiology , Enzyme Activation , Female , Immunohistochemistry , Male , Mice , Mice, Neurologic Mutants , Mitochondria/enzymology , Motor Cortex/enzymology , Motor Cortex/pathology , Motor Neuron Disease/genetics , Motor Neuron Disease/pathology , Motor Neurons/pathology , Nerve Degeneration/enzymology , Nerve Degeneration/pathology , Protein Kinase C/genetics , Protein Kinase C-delta , Protein Transport , Pyramidal Cells/enzymology , Pyramidal Cells/pathology , Pyramidal Tracts/enzymology , Pyramidal Tracts/pathology , Signal Transduction/physiology , Spinal Cord/pathology
10.
J Mol Neurosci ; 21(2): 111-20, 2003.
Article in English | MEDLINE | ID: mdl-14593211

ABSTRACT

Extracellular hypertonicity can induce the phosphorylation of mitogen-activated protein kinases (MAPKs). Of these, both extracellular signal-regulated kinases (ERKs) and the stress-activated kinase p38 have been implicated in neuronal cell survival. Resuscitation with hypertonic saline decreases secondary brain injury after trauma, as well as neuronal damage, after ischemia. Since hypertonicity has been shown to support somatic cell survival, we investigated if hypertonicity can also prevent neuronal cell death via MAPK signaling. Death of postnatal rat corticospinal motoneurons (CSMNs) was induced by serum deprivation, and survival in both isotonic and hypertonic media was assessed after 20 h. Addition of NaCl (4-250 mM) to isotonic medium significantly and dose dependently protected CSMN in enriched cultures, increasing cell survival by up to 70% over that in isotonic medium. This response was not restricted to NaCl; addition of KCl, choline chloride, and sucrose had similar effects on cell survival. In addition, hypertonicity supported the survival of pure CSMN populations, albeit with lower potency. In cortical cell suspensions, hypertonic NaCl (20-100 mM) increased basal phosphorylation of p38 and ERK. The activation of both MAPKs, which was induced by 40 mM NaCl, was transient. Cultivation of CSMNs in media containing the specific p38 inhibitor SB203580 abolished the protective effect of hypertonic NaCl, indicating a central role for p38. We therefore conclude that hypertonicity can prevent neuronal cell death via MAPK signaling.


Subject(s)
Cell Survival/drug effects , Hypertonic Solutions/pharmacology , Mitogen-Activated Protein Kinases/antagonists & inhibitors , Motor Neurons/drug effects , Neuroprotective Agents/pharmacology , Animals , Animals, Newborn , Cell Death/drug effects , Cell Death/physiology , Cell Survival/physiology , Cells, Cultured , Choline/pharmacology , Culture Media, Serum-Free/pharmacology , Dose-Response Relationship, Drug , Enzyme Inhibitors/pharmacology , Hypertonic Solutions/therapeutic use , MAP Kinase Signaling System/drug effects , MAP Kinase Signaling System/physiology , Mitogen-Activated Protein Kinases/drug effects , Mitogen-Activated Protein Kinases/metabolism , Motor Neurons/enzymology , Neuroprotective Agents/therapeutic use , Phosphorylation/drug effects , Potassium Chloride/pharmacology , Pyramidal Cells/drug effects , Pyramidal Cells/enzymology , Pyramidal Tracts/drug effects , Pyramidal Tracts/enzymology , Rats , Rats, Sprague-Dawley , Sodium Chloride/pharmacology , Sucrose/pharmacology , p38 Mitogen-Activated Protein Kinases
11.
Neuron ; 29(1): 73-84, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11182082

ABSTRACT

The EphA4 receptor tyrosine kinase regulates the formation of the corticospinal tract (CST), a pathway controlling voluntary movements, and of the anterior commissure (AC), connecting the neocortical temporal lobes. To study EphA4 kinase signaling in these processes, we generated mice expressing mutant EphA4 receptors either lacking kinase activity or with severely downregulated kinase activity. We demonstrate that EphA4 is required for CST formation as a receptor for which it requires an active kinase domain. In contrast, the formation of the AC is rescued by kinase-dead EphA4, suggesting that in this structure EphA4 acts as a ligand for which its kinase activity is not required. Unexpectedly, the cytoplasmic sterile-alpha motif (SAM) domain is not required for EphA4 functions. Our findings establish both kinase-dependent and kinase-independent functions of EphA4 in the formation of major axon tracts.


Subject(s)
Axons/enzymology , Fetal Proteins/metabolism , Pyramidal Tracts/embryology , Pyramidal Tracts/enzymology , Receptor Protein-Tyrosine Kinases/metabolism , Animals , Brain Stem/cytology , Brain Stem/embryology , Brain Stem/enzymology , Ephrin-A4 , Ephrin-B2 , Fetal Proteins/deficiency , Fetal Proteins/genetics , In Situ Hybridization , Membrane Proteins/biosynthesis , Membrane Proteins/genetics , Mice , Mice, Knockout , Mice, Mutant Strains , Molecular Sequence Data , Motor Cortex/cytology , Motor Cortex/embryology , Motor Cortex/enzymology , Organ Specificity , Prosencephalon/cytology , Prosencephalon/embryology , Prosencephalon/enzymology , Protein Structure, Tertiary/genetics , Pyramidal Tracts/cytology , RNA, Messenger/biosynthesis , Receptor Protein-Tyrosine Kinases/deficiency , Receptor Protein-Tyrosine Kinases/genetics , Receptor, EphA4 , Signal Transduction/genetics , Temporal Lobe/cytology , Temporal Lobe/embryology
12.
Brain Res Dev Brain Res ; 114(2): 229-43, 1999 May 14.
Article in English | MEDLINE | ID: mdl-10320762

ABSTRACT

The complete absence of handling of male rats during neonatal development (from birth to postnatal day 21) correlates with an impairment of latent inhibition [J. Feldon, I. Weiner, From an animal model of an attentional deficit towards new insights into the pathophysiology of schizophrenia, J. Psychiatr. Res. 26 (1992) 345-366.]. Such nonhandling of rats reportedly also correlates with a decreased expression of reduced nicotinamide adenine dinucleotide phosphate-diaphorase (NADPHd) reactivity in the hippocampus in adult rats (6 months of age) when compared with rats of the same age that were handled during the same neonatal period [R.R. Vaid, B.K. Yee, U. Shalev, J.N. Rawlins, I. Weiner, J. Feldon, S. Totterdell, Neonatal nonhandling and in utero prenatal stress reduce the density of NADPH-diaphorase-reactive neurons in the fascia dentata and Ammon's horn of rats, J. Neurosci. 17 (1997) 5599-5609.]. The present study investigated whether such a decrease in NADPHd activity would be detectable at earlier ages. Therefore, the present study assessed the density of nitric oxide (NO) producing neurons in the fascia dentata and Ammon's horn in 28-, 54-, and 118-day-old nonhandled and handled male rats using NADPHd histochemistry and immunohistochemical localization of neuronal isoform of nitric oxide synthase (nNOS), a NADPHd. This showed that in these three age groups, the numbers of NADPHd positive neurons per unit area throughout the hippocampus of rats that received no handling during neonatal development did not differ significantly from those of rats that received regular daily handling. In addition, we found in the rats of 118 days of age that the areal density of nNOS immunopositive neurons in the hippocampus also did not differ significantly between nonhandled and handled rats. Nevertheless, in a parallel study, rats from the same experimental group receiving identical treatments showed the expected impairment of latent inhibition at 4 months of age [R. Weizman, J. Lehmann, S. Leschiner, I. Allmann, T. Stoehr, C. Heidbreder, A. Domeney, J. Feldon, M. Gavish, Long-lasting effect of early handling on the peripheral-type benzodiazepine receptor, Pharmacol. Biochem. Behav. in press.]. These results suggest that nonhandling of rats during the early neonatal period, that does result in impairment in latent inhibition, does not affect the numbers of NO producing neurons in the hippocampus in rats of young ages, including the age of observed impairment of latent inhibition.


Subject(s)
Aging/physiology , Dihydrolipoamide Dehydrogenase/metabolism , Handling, Psychological , Hippocampus/enzymology , Neurons/enzymology , Nitric Oxide Synthase/metabolism , Animals , Animals, Newborn , Dentate Gyrus/enzymology , Dentate Gyrus/growth & development , Functional Laterality , Hippocampus/growth & development , Male , Nitric Oxide Synthase Type I , Pyramidal Tracts/enzymology , Pyramidal Tracts/growth & development , Rats , Rats, Wistar , Reference Values
13.
Ann Neurol ; 43(6): 703-10, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9629839

ABSTRACT

We examined 11 subjects with inherited amyotrophic lateral sclerosis (familial amyotrophic lateral sclerosis, FALS) associated with the most common copper/zinc superoxide dismutase 1 (SOD1) mutation, an alanine for valine substitution in codon 4 (A4V). Autopsies were performed on 5 subjects. The clinical and pathological findings are described and compared with those of 9 sporadic ALS (SALS) subjects. There was no clinical evidence of upper motor neuron (UMN) involvement in 10 FALS A4V subjects. All subjects had lower motor neuron (LMN) signs and electrophysiological evidence of denervation in at least three limbs. All SALS subjects had signs of both UMN and LMN involvement. Pathological studies found severe abnormalities of LMNs in all FALS and SALS subjects. UMN involvement was either absent or mild in the A4V SOD1 FALS subjects and severe in the SALS subjects. Pathological abnormalities in systems other than the motor neurons were more frequent in the FALS A4V subjects. This information suggests that current diagnostic criteria for ALS, requiring dinical evidence for both upper and lower motor neuron involvement, should be modified; ie, the diagnosis should be deemed established when there is evidence of denervation in three or more limbs and a mutation in the gene for SOD1, even without dinical signs of UMN involvement.


Subject(s)
Amyotrophic Lateral Sclerosis/genetics , Amyotrophic Lateral Sclerosis/pathology , Point Mutation , Pyramidal Tracts/pathology , Superoxide Dismutase/genetics , Adult , Aged , Amino Acid Substitution , Amyotrophic Lateral Sclerosis/metabolism , Female , Humans , Male , Middle Aged , Motor Cortex/enzymology , Motor Cortex/pathology , Motor Neurons/enzymology , Motor Neurons/pathology , Phenotype , Pyramidal Tracts/enzymology
14.
J Comp Neurol ; 379(2): 261-70, 1997 Mar 10.
Article in English | MEDLINE | ID: mdl-9050789

ABSTRACT

Activation of serotonin-1A receptors (5-HT(1A)R) in the medulla oblongata lowers sympathetic nerve discharge and blood pressure. Binding sites for 5-HT(1A)R ligands are present in ventral medullary nuclei [e.g., rostral ventrolateral medulla (RVLM), raphe pallidus (RPa), and parapyramidal region (PPR)] that project to sympathetic preganglionic neurons in the intermediolateral cell column (IML). However, the projections and the neurochemical contents of the ventral medullary neurons that are likely to be involved in the hypotensive actions of 5-HT(1A) agonists are unclear. Using a sheep antibody to a fragment of the third intracellular loop of the 5-HT(1A)R, we localized 5-HT(1A)R immunoreactivity (ir) to IML-projecting neurons that were retrogradely labeled with rhodamine beads injected into the IML of adult male rats. The percentages of IML-projecting neurons containing 5-HT(1A)R-ir were 49% in RPa, 34% in PPR, and 44% in RVLM. Using multiple-immunofluorescence labeling, we also demonstrated 5-HT(1A)R-ir in serotonergic (5-HT) and in catecholaminergic (tyrosine hydroxylase; TH-ir) neurons of the ventral medulla. The percentages of 5-HT-ir neurons containing 5-HT(1A)R-ir were 28% in RPa, 18% in PPR, and 31% in raphe obscurus. In addition, 5-HT(1A)R-ir was present in 14% of TH-ir neurons of the RVLM. Moreover, some IML-projecting neurons in the PPR and RPa were doubly immunolabeled for 5-HT(1A)R-ir and 5-HT, and some IML-projecting neurons in the RVLM were doubly immunolabeled for 5-HT(1A)R-ir and TH-ir. These data provide anatomical evidence for the presence of 5-HT(1A)R on serotonergic and catecholaminergic bulbospinal neurons and for their potential role in directly modifying the activity of these ventral medullary neurons.


Subject(s)
Medulla Oblongata/cytology , Pyramidal Tracts/cytology , Receptors, Serotonin/analysis , Serotonin/analysis , Tyrosine 3-Monooxygenase/analysis , Animals , Catecholamines/physiology , Fluorescent Antibody Technique , Male , Medulla Oblongata/chemistry , Medulla Oblongata/enzymology , Neural Pathways , Neurons/chemistry , Neurons/enzymology , Pyramidal Tracts/chemistry , Pyramidal Tracts/enzymology , Rabbits , Raphe Nuclei/chemistry , Raphe Nuclei/cytology , Raphe Nuclei/enzymology , Rats , Rats, Sprague-Dawley , Serotonin/physiology
15.
Vis Neurosci ; 14(2): 241-51, 1997.
Article in English | MEDLINE | ID: mdl-9147477

ABSTRACT

To study the relationship between ocular dominance columns (ODCs) and axonal projections of individual layer 6 pyramidal neurons in the primary visual cortex, neurons were intracellularly labeled with biocytin in live slices prepared from macaque monkeys that had received an intravitreal injection of tetrodotoxin (TTX). The TTX injection indirectly causes a decrease in cytochrome oxidase (CO) expression in the cortical ODCs corresponding to the treated eye (Wong-Riley & Carroll, 1984). Sections from slices with labeled layer 6 neurons were double stained for biocytin and CO, to allow visualization of neuronal processes as well as ODCs. Twenty-seven layer 6 pyramidal neurons in ODC-labeled slices were analyzed. These neurons were classified according to the criteria of Wiser and Callaway (1996). Eight of these are class I neurons, which have dense axonal projections to the monocular layer 4C. The remaining 19 are class II neurons which project primarily to the binocular layers outside 4C. Among class I neurons, two have dense axonal arbors in layer 4C alpha (type I alpha), one in layer 4C beta (type I beta), and two throughout the depth of layer 4C (type IC). None of these neurons have ODC-specific axonal arbors. The remaining three class I neurons have focused axonal projections in layers 4C beta and 4A (type I beta A). All three appear to have axonal arbors predominantly within their home ODC in layer 4C. The axonal arbors of class II neurons do not appear to relate to ODCs in any specific fashion.


Subject(s)
Neurons/cytology , Pyramidal Tracts/anatomy & histology , Visual Cortex/anatomy & histology , Animals , Electron Transport Complex IV/antagonists & inhibitors , Electron Transport Complex IV/metabolism , Functional Laterality , Injections , Lysine/analogs & derivatives , Macaca radiata , Neurons/drug effects , Neurons/enzymology , Pyramidal Tracts/drug effects , Pyramidal Tracts/enzymology , Tetrodotoxin/administration & dosage , Tetrodotoxin/pharmacology , Visual Cortex/drug effects , Visual Cortex/enzymology , Vitreous Body
17.
Anat Embryol (Berl) ; 192(2): 123-36, 1995 Aug.
Article in English | MEDLINE | ID: mdl-7486009

ABSTRACT

A combination of either retrograde or anterograde fluorescent tracer and immunofluorescence histochemistry using the monoclonal antibody specific for the alpha isoform of calcium/calmodulin-dependent protein kinase II (CaM kinase II alpha) was employed to test whether CaM kinase II alpha is expressed in somata of corticospinal neurons and their axons over their whole course. After the injection of carbocyanine dye DiI into the hindlimb area of the primary motor cortex of the rat, corticospinal axons and their terminal arbors were anterogradely labeled: DiI-labeled corticospinal fibers proceeded caudally in the ipsilateral internal capsule, cerebral peduncle and medullary pyramid, crossed at the pyramidal decussation and descended in the ventralmost area of the contralateral dorsal funiculus of the spinal cord. These DiI-labeled corticospinal axons expressed strong CaM kinase II alpha immunoreactivity along their course. However, their terminal arbors within the gray matter of the lumbar cord were very weakly immunostained. With the injection of Fast Blue into the lumbar enlargement of the rat, somata of corticospinal neurons in layer V of the motor cortex were retrogradely labeled. The subsequent immunofluorescent histochemistry revealed that more than 80% of Fast Blue-labeled corticospinal neurons were immunostained with CaM kinase II alpha antibody. The present immunohistochemical study demonstrated that CaM kinase II alpha is strongly expressed in both somata and axons of a majority of corticospinal neurons, although we could not detect this enzyme in the corticospinal terminals in the spinal target areas.


Subject(s)
Axonal Transport/physiology , Calcium-Calmodulin-Dependent Protein Kinases/analysis , Cerebral Cortex/cytology , Neurons/enzymology , Pyramidal Tracts/cytology , Amidines , Animals , Axons/enzymology , Calcium-Calmodulin-Dependent Protein Kinase Type 2 , Calcium-Calmodulin-Dependent Protein Kinases/immunology , Carbocyanines , Cerebral Cortex/enzymology , Female , Fluorescent Antibody Technique, Direct , Fluorescent Dyes , Male , Motor Cortex , Pyramidal Tracts/enzymology , Rats , Rats, Wistar
18.
Neuron ; 11(6): 1023-35, 1993 Dec.
Article in English | MEDLINE | ID: mdl-8274274

ABSTRACT

The Ca(2+)-activated K+ current IAHP, which underlies spike frequency adaptation in cortical pyramidal cells, can be modulated by multiple transmitters and probably contributes to state control of the forebrain by ascending monoaminergic fibers. Here, we show that the modulation of this current by norepinephrine, serotonin, and histamine is mediated by protein kinase A in hippocampal CA1 neurons. Two specific protein kinase A inhibitors, Rp-cAMPS and Walsh peptide, suppressed the effects of these transmitters on IAHP and spike frequency adaptation. The effects of the cyclic AMP analog 8CPT-cAMP were also inhibited, whereas muscarinic and metabotropic glutamate receptor agonists had full effect. Intracellular application of protein kinase A catalytic subunit or a phosphatase inhibitor mimicked the effects of monoamines or 8CPT-cAMP. These results demonstrate that monoaminergic modulation of neuronal excitability in the mammalian CNS is mediated by protein phosphorylation.


Subject(s)
Cyclic AMP-Dependent Protein Kinases/metabolism , Hippocampus/physiology , Histamine/pharmacology , Neurons/physiology , Norepinephrine/pharmacology , Potassium Channels/physiology , Serotonin/pharmacology , Amino Acid Sequence , Animals , Binding Sites , Cyclic AMP/analogs & derivatives , Cyclic AMP/metabolism , Cyclic AMP/pharmacology , Cyclic AMP-Dependent Protein Kinases/antagonists & inhibitors , Hippocampus/enzymology , In Vitro Techniques , Intercellular Signaling Peptides and Proteins , Kinetics , Molecular Sequence Data , Neurons/drug effects , Neurons/enzymology , Peptides/pharmacology , Potassium Channels/drug effects , Pyramidal Tracts/drug effects , Pyramidal Tracts/enzymology , Pyramidal Tracts/physiology , Rats , Rats, Wistar , Thionucleotides/pharmacology , Time Factors
19.
J Neurochem ; 61(6): 2303-10, 1993 Dec.
Article in English | MEDLINE | ID: mdl-8245981

ABSTRACT

We investigated the effects of lithium on alterations in the amount and distribution of protein kinase C (PKC) in discrete areas of rat brain by using [3H]phorbol 12,13-dibutyrate quantitative autoradiography as well as western blotting. Chronic administration of lithium resulted in a significant decrease in membrane-associated PKC in several hippocampal structures, most notably the subiculum and the CA1 region. In contrast, only modest changes in [3H]phorbol 12,13-dibutyrate binding were observed in the various other cortical and subcortical structures examined. Immunoblotting using monoclonal anti-PKC antibodies revealed an isozyme-specific 30% decrease in hippocampal membrane-associated PKC alpha, in the absence of any changes in the labeling of either the beta (I/II) or gamma isozymes. These changes were observed only after chronic (4 week) treatment with lithium, and not after acute (5 days) treatment, suggesting potential clinical relevance. Given the critical role of PKC in regulating neuronal signal transduction, lithium's effects on PKC in the limbic system represent an attractive molecular mechanism for its efficacy in treating both poles of manic-depressive illness. In addition, the decreased hippocampal membrane-associated PKC observed in the present study offers a possible explanation for lithium-induced memory impairment.


Subject(s)
Brain/enzymology , Hippocampus/enzymology , Isoenzymes/metabolism , Lithium Carbonate/pharmacology , Protein Kinase C/metabolism , Animals , Autoradiography , Hippocampus/drug effects , Male , Organ Specificity , Phorbol 12,13-Dibutyrate/metabolism , Pyramidal Tracts/enzymology , Rats , Rats, Sprague-Dawley , Tritium
20.
Brain Res Mol Brain Res ; 19(4): 269-76, 1993 Sep.
Article in English | MEDLINE | ID: mdl-8231730

ABSTRACT

We used oligonucleotide in situ hybridization and film autoradiography to quantitate the distributions of protein kinase C (PKC) alpha, beta, gamma, and epsilon mRNAs in subregions of rabbit hippocampus. Levels of each of the hippocampal PKC isozyme mRNAs and patterns of their regional distributions were remarkably invariant between individuals. Within stratum pyramidale, the highest levels of PKC alpha mRNA were in the CA2 region, while PKC beta mRNA was maximally expressed in CA1, and PKC epsilon mRNA in CA3; PKC gamma mRNA was abundantly expressed throughout Ammon's horn. Previous experiments employing quantitative autoradiography for [3H]PDBU (Olds et al., Science, 245 (1989) 866-869) revealed an increase in membrane-bound PKC in the CA1 region of rabbit hippocampus up to 3 days following classical conditioning of the nictitating membrane response. We report here that there were no differences in levels of PKC alpha, beta, gamma, or epsilon mRNA between conditioned and control rabbits in any hippocampal region one day after training. These data are consistent with the hypothesis that PKC is post-translationally activated and translocated to the membrane during memory storage.


Subject(s)
Conditioning, Classical/physiology , Hippocampus/enzymology , Isoenzymes/biosynthesis , Nictitating Membrane/physiology , Protein Kinase C/biosynthesis , RNA, Messenger/metabolism , Acoustic Stimulation , Animals , Autoradiography , Base Sequence , Blotting, Northern , In Situ Hybridization , Male , Molecular Sequence Data , Oligonucleotide Probes , Organ Specificity , Phosphorus Radioisotopes , Pyramidal Tracts/enzymology , RNA, Messenger/analysis , Rabbits , Reference Values
SELECTION OF CITATIONS
SEARCH DETAIL
...